[144] Innovative Eyewear Inc SEC Filing

Rhea-AI Filing Summary

Form 144 notice by a person associated with Innovative Eyewear Inc. (ticker LUCY) proposing a sale under Rule 144. The filer lists 759 shares of Common stock to be sold, with an aggregate market value of $1,641.08, against approximately 4,574,600 shares outstanding, and an approximate sale date of 09/24/2025 on NASDAQ. The securities were acquired as an RSU grant on 08/19/2025, with 7,200 RSU units noted and payment listed as cash. The filing also discloses three sales by David Cohen in the past three months totaling 2,985 shares for gross proceeds of $5,983.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and contains signature/attestation language required by the form.

Positive

• Compliance disclosure filed under Rule 144 documenting proposed sale and recent sales history
• Acquisition source disclosed as an RSU grant on 08/19/2025 with 7,200 units noted
• Broker and market details provided (Raymond James & Associates; NASDAQ)

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice documenting proposed sale of 759 common shares from recent RSU grant; disclosures appear standard.

The filing identifies the sale as a Rule 144 notice for 759 common shares with an approximate sale date and exchange specified, and it documents the acquisition source as an RSU grant on 08/19/2025. Prior sales by the same person over the past three months are itemized with dates and gross proceeds. The form includes the required attestation regarding material nonpublic information. From a compliance perspective, the notice contains the core elements regulators expect for a Rule 144 sale notice: issuer identification fields, broker details, amount and market value, acquisition details, and recent sales history. The filing does not include any additional disclosures of material developments.

Corporate Governance Expert

TL;DR: Disclosure is procedural and limited; it documents insider-related sales but shows no disclosed governance or material event issues.

The document records a planned sale tied to an RSU grant and lists past individual sales, providing transparency about insider selling activity. It contains the standard attestation that no undisclosed material adverse information is known to the seller. There are no statements in the filing indicating departures, related-party transactions beyond the sales, or unspecified material events affecting corporate governance. As presented, the filing is a routine insider sale notification without additional governance concerns disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St Petersburg FL 33716	759	1641.08	4574600	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			7200	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Cohen 2566 NE 206th Ter Miami FL 33180	Common	08/19/2025	2225	4422.00
David Cohen 2566 NE 206th TER Miami FL 33180	Common	09/10/2025	245	501.00
David Cohen 2566 NE 206th TER Miami FL 33180	Common	09/22/2025	515	1060.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for LUCY disclose about the proposed sale?

The notice proposes selling 759 common shares with an aggregate market value of $1,641.08, approximately on 09/24/2025, to be executed on NASDAQ.

How were the securities being sold acquired according to the filing?

The securities were acquired as an RSU grant on 08/19/2025; the filing lists 7,200 units acquired and cash as the nature of payment.

Does the filing disclose recent sales by the same person?

Yes; it lists three sales by David Cohen on 08/19/2025 (2,225 shares), 09/10/2025 (245 shares), and 09/22/2025 (515 shares), totaling 2,985 shares for gross proceeds of $5,983.00.

Which broker is named for the proposed transaction?

The broker named is Raymond James & Associates, Inc. with an address in St. Petersburg, FL.

Does the Form 144 include any disclosure of material nonpublic information?

The filer includes the standard representation that they do not know of any material adverse information about the issuer that has not been publicly disclosed.